Accession Number: | 0001415889-23-000669 |
Date: | 2023-01-05 |
Issuer: | PTC THERAPEUTICS, INC. (PTCT) |
Original Submission Date: |
SOUTHWELL DAVID P
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD, NJ 07080
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-01-05 | A | 4,000 | a | $0.00 | 10,500 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 39.42 | 2023-01-05 | deemed execution date | A | 10,000 (a) | 2033-01-04 | common stock 10,000 | $39.42 | 10,000 | direct |
ID | footnote |
---|---|
f1 | restricted stock units granted on january 5, 2023 that vest over one year, with five-twelfths (5/12) of the shares underlying the rsus vesting on june 6, 2023 and the remaining seven-twelfths (7/12) of the original shares underlying the rsus vesting on january 5, 2024. the reporting person has elected to defer receipt of all vested shares until the earliest to occur of (a) the date that is six months following separation of service from the issuer, (b) a change in control event and (c) death. |
f2 | this option was granted on january 5, 2023 and vests over one year in twelve equal monthly installments, commencing on february 5, 2023. |